Phase 1b: Multiple Ascending Dose Study (NCT03014609) Study Title: "Safety, Tolerability, PK and PD of Multiple Doses of Cagrilintide in Subjects With Type 2 Diabetes" Status: Completed Phase: Phase 1b Enrollment: 56 participants with T2D Study Period: 2017-2018 Design: Randomized, double-blind, placebo-controlled Duration: 12 weeks Dose Range: 0.3-4.5 mg SC weekly Population: T2D, BMI 25-40, HbA1c 7-10% Key Results: Weight Loss: 6.0 kg (4.5 mg dose) vs
Here is the quick reference: That is the short answer
Pharmacological mechanism is well-described in the peer-reviewed literature
KP can improve in the 4th decade of life- usually mid 30s
Glutathione benefits Cellular Detoxification One of the most important benefits of glutathione is its role in detoxifying the body
Retatrutide availability is primarily through research chemical suppliers, and the market is growing as more researchers begin exploring this triple-agonist peptide